The Panel reviewed recent US tort reform developments, noting a planned February 2026 London briefing by Sabrina Miesowitz covering regulatory updates, tort reform and lobbying activity. Ongoing concerns around large‑loss disclosure, including inconsistent broker practices and insufficient loss‑run transparency, were highlighted, with members agreeing to continue promoting best practice across the market

2025/26 priorities were discussed including PFAS, microplastics, silica and processed‑food exposures, with a working group to advance exclusion wording and horizon scanning into 2026.

An update on the AI Scenarios Project confirmed a final report is due by year‑end. Claims Committee updates included a focus on social‑media‑related claims and enhanced mentoring initiatives.

Further updates covered the Bodily Injury Index, greenwashing exclusion, LTA wording, Canadian French‑language rules.